Does Age Matter for IVF in Thailand? Age-Specific Medical Evaluation Criteria and Decision-Making Basis
In the Fertility Clinic, Age Is Never the Only Answer
Every day, I encounter the same question: "Doctor, I am 43 years old. Is there still hope for me to do IVF in Thailand?" My answer is never a simple "yes" or "no." Instead, I first open a complete fertility assessment report—checking AMH, FSH, and the antral follicle count. Age is a starting parameter, but it never determines the outcome alone. In the decision-making process for IVF in Thailand, what truly matters is a set of indicators, not just the year of birth.
Direct Answer: Does Age Matter for IVF in Thailand?
Thailand has no legal upper age limit for IVF, but there are clear medical evaluation criteria. The core conclusion is: Age affects the ovaries' response to ovulation-stimulating drugs, egg quality, the normal chromosome rate of embryos, and ultimately the live birth rate, but it is not an eligibility criterion for entering the IVF process.
Clinical data shows a clear gradient in live birth rates across age groups:
- Under 35: Live birth rate approximately 40%–50%
- 35–40 years: Live birth rate approximately 25%–35%
- 40–43 years: Live birth rate approximately 10%–15%
- 43–45 years: Live birth rate approximately 3%–5%
- Over 45: Live birth rate with own eggs less than 1%
Thai fertility centers will not directly refuse older patients, but they require signing an informed consent form before treatment, clearly acknowledging the age-related decline in success rates and increased pregnancy risks.
The Doctor's Perspective: Four Medical Rationales Behind Age
From a reproductive medicine standpoint, the impact of age on IVF occurs through the following mechanisms:
Decline in egg quality. A woman is born with about 1–2 million follicles, which reduces to about 300,000–400,000 by puberty. After age 35, the rate of follicle atresia accelerates, and the aneuploidy rate of chromosomes in remaining eggs increases significantly with age. The embryo chromosome abnormality rate is about 30% at age 35, about 60% at age 40, and over 90% at age 45. This is the most critical factor affecting IVF success in advanced maternal age.
Decreased ovarian reserve. AMH is the most stable indicator for assessing ovarian reserve and declines irreversibly with age. AMH below 1.0 ng/mL indicates diminished reserve, and below 0.5 ng/mL indicates severely diminished reserve, directly limiting the number of eggs that can be retrieved.
Changes in endometrial receptivity. Increasing age affects blood flow supply and receptor expression in the endometrium, reducing embryo implantation rates. Even if older patients obtain normal embryos, the probability of implantation failure is higher than in younger patients.
Increased pregnancy complications. The risks of diabetes, hypertension, miscarriage, and preterm birth in advanced maternal age pregnancies are significantly higher than in age-appropriate pregnancies. When evaluating age, Thai reproductive doctors not only assess ovarian function but also evaluate whether the patient's overall health can withstand pregnancy.
Therefore, when Thai reproductive doctors assess age, they focus not on "can it be done at a certain age," but on "at this age, does the patient's ovarian reserve allow for obtaining usable embryos, and can her physical condition tolerate pregnancy?"
Differences in Clinical Pathways by Age Group
Treatment strategies for IVF in Thailand vary significantly by age group, as shown in the table below:
| Age Group | Ovarian Reserve Characteristics | Recommended Protocol | Key Focus |
|---|---|---|---|
| Under 35 | Adequate reserve, good egg quality | Conventional ovarian stimulation, fresh or frozen embryo transfer | Avoid OHSS, single embryo transfer |
| 35–40 years | Reserve starting to decline, acceptable quality | Mild or conventional stimulation, PGT optional | Control stimulation protocol, reduce aneuploidy |
| 40–43 years | Significantly decreased reserve, declining quality | High-dose stimulation, PGT mandatory | Obtain sufficient eggs, screen for normal embryos |
| 43–45 years | Severely diminished reserve, poor quality | Mini-stimulation or natural cycle, PGT mandatory | Cumulative cycles, embryo biopsy |
| Over 45 | Extremely low reserve, very poor quality | Egg donation as primary option | Uterine assessment, pregnancy risk management |
Interpreting Test Indicators: Three Decisive Numbers
In the age assessment for IVF in Thailand, three indicators are the core basis for doctors' decisions:
AMH (Anti-Müllerian Hormone)
- >1.5 ng/mL: Normal ovarian reserve
- 1.0–1.5 ng/mL: Mildly diminished reserve
- 0.5–1.0 ng/mL: Significantly diminished reserve
- <0.5 ng/mL: Severely diminished reserve
AMH is not affected by the menstrual cycle and can be checked at any time, making it the most convenient indicator for assessing ovarian reserve. However, note that AMH results can be influenced by recent use of birth control pills, vitamin D levels, thyroid function, and other factors.
FSH (Follicle-Stimulating Hormone)
- <8 IU/L: Normal ovarian function
- 8–12 IU/L: Mildly decreased function
- 12–20 IU/L: Significantly decreased function
- >20 IU/L: Severely decreased function
FSH should be checked on days 2–4 of the menstrual cycle. A single abnormal result is not definitive and should be combined with AMH and AFC for a comprehensive assessment.
Antral Follicle Count (AFC)
- >15: Adequate reserve
- 10–15: Normal reserve
- 5–9: Reduced reserve
- <5: Severely diminished reserve
AFC is measured via transvaginal ultrasound on days 2–4 of the menstrual cycle, directly reflecting the number of basal follicles. An FSH/LH ratio greater than 2 also indicates diminished ovarian reserve and may predict a poor response to ovarian stimulation.
Most Commonly Overlooked Details: Test Timeliness and Document Preparation
In clinical practice, several details are often overlooked and can directly affect the treatment process:
- AMH testing has no time limit, but results are influenced by various factors; it is recommended to be done within 3 months before trying to conceive.
- FSH must be tested in the early follicular phase (days 2–4). FSH results obtained outside this window cannot be used to assess ovarian reserve.
- Documents for Thailand IVF registration: Passport must be valid for at least 6 months, marriage certificate must be notarized and translated, and some hospitals require a medical check-up report from the last 6 months. It is recommended to apply for a visa 1 month in advance.
- Male partner tests: Semen analysis requires 3–5 days of abstinence; chromosome testing requires only one blood draw with no time limit. It is recommended to complete all tests before traveling to Thailand.
- Validity of test results: Infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis) is usually valid for 6 months, chromosome testing is valid for life, and AMH and FSH are recommended within 3 months.
- Genetic counseling: Patients with a family history of genetic disorders or previous adverse pregnancy outcomes should seek genetic counseling in advance to determine if PGT-M or PGT-SR is needed.
These details may seem minor, but any lack of preparation can lead to an inability to start the cycle as planned after arriving in Thailand, resulting in additional time and expense.
Common Pitfalls: Five Frequent Decision-Making Mistakes
In consultations, several types of decision-making mistakes recur and warrant attention:
Mistake 1: Looking only at age, not reserve. A 42-year-old with AMH 2.0 and a 42-year-old with AMH 0.3 have completely different treatment plans—the former may still have a chance with own eggs, while the latter should directly consider egg donation. Making decisions based solely on age is the most common error.
Mistake 2: Believing IVF in Thailand can reverse ovarian age. Ovulation-stimulating drugs can only utilize the basal follicles of the current cycle; they cannot increase the total number of follicles or improve egg quality. The impact of age on egg quality is irreversible, and no regimen can reverse it.
Mistake 3: Ignoring the male partner's age factor. When the male partner is over 40, sperm DNA fragmentation rate increases, affecting embryo developmental potential and implantation rate. Before IVF in Thailand, the male partner's sperm quality should be assessed simultaneously, and DFI testing should be done if necessary.
Mistake 4: Believing PGT can solve all age-related problems. PGT can screen for chromosomal aneuploidy, but it cannot improve mitochondrial function, gene imprinting abnormalities, or other age-related egg quality issues. PGT cannot improve egg quality; it can only screen for relatively normal embryos.
Mistake 5: Neglecting endometrial assessment. Older patients often have endometrial polyps, adhesions, fibroids, adenomyosis, etc. Transferring without treatment can lead to implantation failure or early miscarriage. Hysteroscopy or ultrasound evaluation is recommended before transfer.
Frequently Asked Questions
Q: Can I still do IVF in Thailand with low AMH?
A: Low AMH does not mean you cannot do it, but expectations need to be adjusted. When AMH is below 0.5 ng/mL, it is recommended to use a mini-stimulation protocol to accumulate embryos, or directly consider egg donation. The key is whether usable normal embryos can be obtained.
Q: What preparations are needed for advanced maternal age IVF in Thailand?
A: Complete fertility assessment (AMH, FSH, AFC), chromosome testing, infectious disease screening, uterine cavity evaluation, male partner semen analysis + DNA fragmentation testing. Metabolic-related tests such as vitamin D, thyroid function, and blood sugar are also recommended.
Q: Is pre-treatment preparation needed before IVF in Thailand?
A: It is recommended to start supplementing with folic acid, Coenzyme Q10, vitamin D, and adjusting sleep and diet 3 months in advance. However, it must be clear that preparation cannot reverse the impact of age on egg quality; it only helps improve physical condition and the egg development environment.
Q: Is there still hope for IVF in Thailand for women over 43?
A: The live birth rate with own eggs is less than 5%, but there are still successful cases after PGT screening for normal embryos. It is recommended to also learn about egg donation options as a backup, and not to pin all hopes on using own eggs.
Q: What is the specific process for IVF in Thailand, and how long does it take?
A: The standard process includes: pre-treatment tests → ovarian stimulation (10–14 days) → egg retrieval → fertilization → embryo culture (5–6 days) → PGT screening (7–14 days) → frozen embryo → transfer → luteal phase support → pregnancy test. From initial tests to completing transfer, it is recommended to allow 4–6 months.
Observations from a Practitioner: Key Variables Beyond Age
In my years working at Thai fertility centers, I have observed several easily overlooked facts:
The laboratory's embryo culture conditions and PGT technical capability have a huge impact on the embryo utilization rate for older patients. The same batch of eggs can yield completely different blastocyst formation rates and normal rates in different labs. When choosing a fertility center, focus on confirming its laboratory qualifications, incubator conditions, biopsy, and freezing techniques.
Frozen embryo transfer has advantages over fresh embryo transfer in older patients. Frozen transfer allows selecting the optimal time for transfer based on endometrial conditions, avoiding the adverse effects of the hormonal environment after stimulation on the endometrium. Older patients are advised to prioritize a frozen embryo transfer strategy.
Luteal phase support is a critical step after transfer. Older patients may require stronger luteal support protocols, including a combination of intramuscular progesterone, vaginal gel, and oral medications. Luteal phase insufficiency is one of the hidden causes of early miscarriage in older patients.
Finally, advances in genetic testing technology are changing the decision-making space for older patients. PGT-A screening accuracy for chromosomal aneuploidy has exceeded 95%, providing more data support for treatments using own eggs that might otherwise have been abandoned. However, it must be clear that PGT cannot create normal embryos; it can only screen from existing embryos.
Doctor's Advice: If You Are Considering IVF in Thailand
My advice is:
- Assess first, then discuss the plan. Complete the three basic tests: AMH, FSH, and AFC. Do not make decisions based solely on age. For those over 40, hysteroscopy and male partner sperm DNA fragmentation testing are also recommended.
- Set realistic expectations. Understand the success rate range corresponding to your age to avoid unrealistic hopes. The success rate with own eggs after 43 is less than 5%. This is not to discourage but to help make rational choices.
- Plan your time in advance. From initial tests to completing transfer, it is recommended to allow 4–6 months. If your passport is valid for less than 6 months, renew it before arranging your trip.
- Prepare a backup plan. Older patients should learn about legal alternative paths such as egg donation and embryo donation in advance, to avoid a decision vacuum after a failed cycle with own eggs.
- Choose a reputable fertility center. Confirm laboratory qualifications, embryo culture conditions, and PGT technical capability. Look at the lab's actual data, not just promotional materials.
- Do not neglect male partner tests. Semen analysis and DNA fragmentation testing should be completed before traveling to Thailand. The male factor has a greater impact in older couples than commonly thought.
Age is an important parameter in the decision-making process for IVF in Thailand, but it never determines the outcome alone. What truly determines the treatment path is a complete fertility assessment report and the rational decision made by the doctor and patient based on that report. The goal of reproductive medicine is to provide the most suitable solution for each age group while respecting biological laws.
